Last reviewed · How we verify

NCT06615037

Strength Profile of Hip Joint in Females With Primary Dysmenorrhea During Menstrual Cycle

Completed Last updated 5 February 2025
What this trial tests

trial testing Assess Hip joint strength by Biodex isokinetic dynamometer (System 4 Pro) in Primary Dysmenorrhea in 40 participants. Completed in 15 January 2025.

Timeline
1 October 2024
Primary endpoint
15 January 2025
15 January 2025

Quick facts

Lead sponsorCairo University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date1 October 2024
Primary completion15 January 2025
Estimated completion15 January 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 25, female only, with Primary Dysmenorrhea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to investigate the effect of primary dysmenorrhea on strength of hip joint muscles in females.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Primary Dysmenorrhea

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06615037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing